Compare CTSO & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTSO | ATCH |
|---|---|---|
| Founded | 1997 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9M | 27.5M |
| IPO Year | 2008 | 2024 |
| Metric | CTSO | ATCH |
|---|---|---|
| Price | $0.38 | $0.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.38 | $1.00 |
| AVG Volume (30 Days) | 86.7K | ★ 1.2M |
| Earning Date | 05-01-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.79 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $22,503,908.00 | N/A |
| Revenue This Year | $10.34 | $84.47 |
| Revenue Next Year | $22.41 | $39.32 |
| P/E Ratio | ★ N/A | $3.83 |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.35 | $0.14 |
| 52 Week High | $1.22 | $1.92 |
| Indicator | CTSO | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 45.05 |
| Support Level | $0.36 | $0.18 |
| Resistance Level | $0.74 | $0.22 |
| Average True Range (ATR) | 0.03 | 0.01 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 23.00 | 25.37 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.